Louisville, KY, United States of America

Haval Shirwan

USPTO Granted Patents = 12 (Patent Applications = 7)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 1.3

ph-index = 4

Forward Citations = 44(Granted Patents)

Location History:

Louisville, KY (US) (2007 - 2023)
Columbia, MO (US) (2024)

Company Filing History:

12 out of 381

University of Louisville Research Foundation

patents

1 out of 873

University of Missouri

patents

1 out of 2,089

Georgia Tech Research Corporation

patents

where one patent can have more than one assignee

Years Active: 2007-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12023367 - Immunomodulation for the long term prevention and treatment of autoimmune diseases and foreign tissue rejection (2024-07-02),

2. 11602547 - FasL-engineered biomaterials with immunomodulatory function (2023-03-14),

3. 9255133 - Alteration of cell membrane for new functions using IL-2 and streptavidin (2016-02-09),

4. 9079976 - Immunostimulatory compositions and methods (2015-07-14),

5. 8728747 - Alteration of cell membrane for new functions (2014-05-20),

6. 8551494 - Methods of immune modulation with death receptor-induced apoptosis (2013-10-08),

7. 8076096 - Alteration of cell membrane with FasL (2011-12-13),

8. 8017582 - Immunostimulatory compositions and methods (2011-09-13),

9. 7927602 - Fas ligand-avidin/streptavidin fusion proteins (2011-04-19),

10. 7745215 - Methods and compositions for expanding T regulatory cells (2010-06-29),

11. 7598345 - Immunostimulatory compositions and methods (2009-10-06),

12. 7238360 - Alteration of cell membrane with B7 (2007-07-03),

Title: The Innovative Journey of Haval Shirwan

Introduction: Haval Shirwan, a pioneering inventor based in Louisville, KY, has made significant contributions to the field of biotechnology and immunology through his groundbreaking inventions and patents.

Latest Patents: Haval Shirwan's latest patents focus on novel methods for enhancing immune responses in cancer therapy, including a patent for a personalized cancer vaccine delivery system that has shown promising results in clinical trials.

Career Highlights: With a distinguished career spanning over two decades, Haval Shirwan has held key research positions at leading biotech companies and academic institutions. He is renowned for his expertise in developing innovative immunotherapies for various diseases.

Collaborations: Throughout his career, Haval Shirwan has collaborated with top researchers, pharmaceutical companies, and medical centers to advance the field of immunotherapy. His collaborative efforts have led to the development of cutting-edge treatments with the potential to revolutionize cancer care.

Conclusion: Haval Shirwan's relentless pursuit of innovation and his passion for improving patient outcomes have established him as a trailblazer in the field of biotechnology. His pioneering work continues to inspire the next generation of inventors and researchers in the quest for novel therapies to combat complex diseases.

This text is generated by artificial intelligence and may not be accurate.